Schizophrenia is a debilitating mental illness that affects 1% of the world's population, with a heritability of 0.70-0.85 attributable to complex inheritance. 5 Despite extensive studies, its molecular causes have remained unidentified. Like many common diseases, it is believed to be multifactorial in origin, with both genetic and environmental contributions playing important roles in determining the symptoms. Several neurotransmitters, including dopamine, glutamate and serotonin are thought to be important to the disease, and significant associations with genes of the glutamate neurotransmitter and related systems have recently been reported. 6, 7 Although a defect in neurotransmission involving g-amino butyric acid (GABA) in schizophrenia was first proposed in the early 1970s, followed by extensive investigations on the GABAergic system in schizophrenic subjects, [1] [2] [3] [4] the lack of molecular genetic evidence has left the GABAergic system out of the roster of leading candidate genes for schizophrenia.
The type A g-amino butyric acid receptors (GABA A ) are the major inhibitory receptors in the CNS. 8, 9 Among different subunit combinations, the a 1 /b 2 /g 2 -containing heteropentamer is the dominant subtype in mammalian brains. 10, 11 To test the potential involvement of GABA A receptor genetics in the molecular etiology of schizophrenia, single-nucleotide polymorphisms (SNPs) and SNP-based haplotypes in the genes of GABA A receptors have been examined in the present study. In all, 19 SNPs in the GABA A a 1 , b 2 , g 2 , e and p subunit genes were assessed for possible association with schizophrenia ( Table 1) . Five of them were discovered, and the others confirmed, through sequencing of PCR-amplified DNA samples. None of the nine SNPs identified in the a 1 , g 2 , e and p subunit genes was associated with schizophrenia (P40.05; Table 1 ). On the other hand, five of the 10 SNPs in the b 2 subunit gene showed a significant association. Accordingly, a detailed investigation of the SNPs in the GABA A receptor b 2 subunit gene (GABRB2) was carried out.
Human GABRB2 is widely expressed in different brain regions, especially the cerebellum. 12 It is located on chromosome 5 at 5q34 close to 5q33.2, which has been identified through genome-wide linkage analysis as one of the susceptibility loci for schizophrenia. 13, 14 In the present study, population association and linkage disequilibrium (LD) analyses were carried out on schizophrenic patients and unaffected subjects of Han Chinese origin for 10 SNPs within GABRB2, spanning approximately 13 kb from B1 kb upstream of exon 6 to B200 bp downstream of exon 9. Five of them, all located in introns 7 and 8, showed significant association with susceptibility to schizophrenia both in an initial screening, and upon further testing with increased sample sizes of schizophrenics and controls (Table 1) . These five positive SNPs include one novel SNP at base 1584 of intron 7 within the sequence TTGTATC(G/T)ATTACAG, which is designated B2I7G1584T, and four previously reported SNPs, rs1816071, rs194072, rs252944 and rs187269 (dbSNP database). The genotype frequencies of all the five SNPs did not deviate from Hardy-Weinberg equilibrium for either the control or the patient group when tested with the program GENEPOP. 15 At the allele level, the minor allele of each of the five positive SNPs was found to increase schizophrenia risk (Table 1) Genotype frequency differences between the schizophrenic and control groups were also analyzed. As shown in Table 1 , highly significant overall genotype association with schizophrenia was observed for rs252944 (P ¼ 0.0018) and rs187269 (P ¼ 0.0031), and significant association observed for B2I7G1584T (P ¼ 0.0195), rs1816071 (P ¼ 0.0096) and rs194072 (P ¼ 0.0044).
The effect of each of the five positive SNPs on schizophrenia susceptibility was further assessed in Table 2 . The risk of schizophrenia for individuals having one or two minor alleles (m/m or m/M) at any of the five SNP sites is estimated to be about two times higher (OR ¼ 1.89-2.61) than individuals with two copies of the major allele (M/M; P ¼ 0.0010-0.0079). A homozygous-minor-allele (m/m) genotype increases schizophrenia susceptibility over the majorallele-containing genotypes (M/m þ M/M) in the cases of rs187269 (P ¼ 0.0046; OR ¼ 4.60), rs1816071 (P ¼ 0.0139; OR ¼ 2.86) and rs252944 (P ¼ 0.0267; OR ¼ 5.12). These results thus point to a significant enhancement of the risk of schizophrenia by the a Cluster ID of SNPs in dbSNP at NCBI (dbSNP Home Page) with prefix of rs, whereas SA1-3 (base 6 102 243 of Contig NT_023133.11 within GABRA1), B2I7G1584T (base 5 569 733 of Contig NT_023133.11 within GABRB2), SG2-3 (base 6 332 114 of Contig NT_023133.11 within GABRG2), SG2-6 (base 6 340 487 of Contig NT_023133.11 within GABRG2) and EP-1 (base 15 048 670 of Contig NT_023133.11 within GABRP) are SNPs discovered in this study. M ¼ major allele; m ¼ minor allele. b SCH ¼ schizophrenics; CON ¼ normal control. c P-values were calculated to test allele frequency differences between schizophrenic and control groups. OR ¼ odds ratio; 95% CI ¼ 95% confidence interval. d P-values were tested to evaluate the overall genotype differences between the schizophrenic and control groups. P-values are given in italics for those o0.05 (significant), or o0.01 (very significant). minor alleles. To compare the minor-allele homozygote and the heterozygote, association analysis was performed separately for m/m vs M/M and M/m vs M/M. The results suggest that the homozygous minor-allele genotypes tend to favor susceptibility to schizophrenia over the heterozygous genotypes, but an increased sample size would be needed before a firm conclusion can be drawn in this regard.
To further define the contribution of the five possible SNPs to schizophrenia susceptibility, haplotype associations with the disease were evaluated for all the possible two-SNP combinations of these five SNPs (Table 3) . Among the two-loci haplotypes, rs1816071-rs187269, rs252944-rs187269 and rs194072-rs187269 yielded asymptotic P-values, derived from the model-free w 2 statistics, 16, 17 that were less than 0.00001 for w 2 distribution with four degrees of freedom (Table 3) . None of the 10 000 replicates in the permutations computed by the EHPLUS program produced any empirical P-value that exceeded the asymptotic P-values from the observed data, thus pointing to a strong association between these three two-loci haplotypes and schizophrenia. The remaining two-SNP combinations also showed significant association with schizophrenia, with P-value ranging from 0.0003 to 0.0149. In addition, pair-wise linkage disequilibrium analysis (Table 3) showed that the five positive SNPs were highly linked with D 0 value ranging between 0.6645 and 0.9687, further supporting the haplotype associations.
The frequencies of the three-SNP haplotypes were likewise found to be in LD with schizophrenia, especially for the haplotype rs194072-rs252944-rs187269 (w 8df 2 ¼ 38.72, Po1.0 Â 10 À5 ). Upon the permutation of 10 000 replicates, the empirical P-value was smaller than the asymptotic P-value in this case. The empirical evidence thus further supported its disease association.
Four of the other five SNPs tested in GABRB2, namely rs2303055, rs967771, rs1644522 and rs1644436, were not significantly associated with the disease at either the allele or the genotype level (P40.05; Table 1 ). However, the association of rs1816072 with the disease, while insignificant (P ¼ 0.1044) at the genotype level, was marginally significant (P ¼ 0.0266; OR ¼ 1.55, 95% CI 1.05-2.29; Table 1 ) at the allele level. Two haplotypes formed by the four negative SNPs were estimated and found not to be significantly associated with schizophrenia (rs2303055-rs967771,
The present study demonstrated that the five SNPs B2I7G1584T, rs1816071, rs194072, rs252944 and rs187269 in introns 7 and 8 of GABRB2 (Figure 1 ) were significantly associated with susceptibility to schizophrenia in Han Chinese. Our results suggest that the GABRB2 gene might be responsible for the previously reported positive linkage of chromosomal locus 5q33.2 with schizophrenia. 13 So far, no other gene has been found in the neighboring sequences up to 351 960 bp upstream (GABRA6) and 927 375 bp downstream (LOC63920) of the block of five positive SNPs (Figure 1) . Although crossethnic multicenter studies are needed before the observed associations can be generalized, the fact that our association analysis and the earlier linkage study were based on samples from different ethnic groups increases the likelihood that the observed association might be multiethnic in nature.
The potential functional consequences of the minor alleles of the five positive SNPs, as well as interactions between GABRB2 and other plausible candidate genes in determining schizophrenia susceptibility, 6, 7, 18, 19 require further investigation in order to better understand the network of genetic factors underlying schizophrenia. It is known that there are at least two isoforms of GABRB2 expression products, 20 and the possibility exists that the five positive SNPs may modulate transcriptional regulation, such as alternative splicing and mRNA expression, of GABRB2, thereby influencing schizophrenic phenotype expression, 21 as has been suggested for the g 2 subunit of GABA A receptor. 22 While the minor alleles at the five loci increase disease susceptibility, they are neither necessary nor sufficient for the development of schizophrenia. The present study thus supports a multifactorial causation. By linking a GABA A receptor gene for the first time to schizophrenia, however, it has provided important evidence for the involvement of GABAergic processes in the etiological mechanism of the disease. Refer to Table 1 for abbreviations. P-values are given in italics for those o0.05 (significant), or o0.01 (very significant).
Materials and methods

Study subjects
Peripheral blood samples were collected from Shanghai Mental Health Center with informed consent from unrelated Han Chinese subjects. Schizophrenics (mean age of onset 26.7 years; mean age 47.9) were diagnosed according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). 23 All patients displayed at least two of the following symptoms for a period of 1 month or more (except where successfully treated): delusion, hallucination, disorganized speech, grossly disorganized or catatonic behavior. Unrelated healthy Han Chinese (mean age 33.5 years) served as controls. All control individuals were interviewed to exclude any history of psychiatric disorders. All successfully genotyped results were included for disease association studies.
SNP discovery and genotyping
Genomic DNA was prepared from blood samples by using the DNA purification kit from Amersham, and diluted to 100 ng/ml. Primers were designed in an adjacent-primer-overlapping-200-base-pairs manner as described by Primer3 (Primer3 website). The specificity of each potential primer was checked through nBlast of the National Center for Biotechnology Information (Blastn Home Page). Only pairs of both forward and reverse primers with less than five hits to the human genome were accepted as specific primers. PCR was performed in a final volume of 20 ml containing 10 ng sample DNA, 75 nmol/l of each primer, 50 nmol/l of each dNTP, 2.5 mmol/l MgCl 2 and 1 U Taq DNA polymerase (Amersham). PCR amplification consisted of denaturation at 941C for 5 min, followed by 40 cycles of 1 min at 941C, 1 min at the annealing temperature optimum for each pair of primers, 90 s at 721C, followed by a final extension step at 721C for 5 min. PCR products were resolved on 1.5% agarose gel electrophoresis, and stained with ethidium bromide to confirm the specificity of the products generated. PCR products were purified by Montaget PCR 96 Purification kit (Millipore). Each sequencing reaction contained 2 ml ABI PRISM s BigDyet Terminator (v.2.0), 5 ml purified PCR products and 1 mmol/l of primer. Sequencing cycling conditions consisted of 1 min denaturation at 961C, followed by 34 cycles of 961C for 30 s, 501C for 30 s and 601C for 3min. Sequencing products were purified by AutoSeq96 Plates containing DNA Grade Sephadex G-50 (Amersham). The purified products were then denatured at 951C for 5 min with addition of 5 ml hi-deionized formamide, and run on the ABI PRISM s model 3100 capillary DNA sequencer. Sequence chromatograms were aligned and analyzed for SNPs by the PolyPhred software. 24 The SNPs suggested by PolyPhred based on automated sequencer traces were double checked manually by two independent researchers to ensure the accuracy of the genotype calls. All of the SNPs analyzed were located within the high-quality region of the chromatogram, from base 200 to base 400, and occasional low-quality sequencing passes were re-run. Samples from both patient and control groups were included in the same experimental batches to minimize batch-to-batch variations in genotyping.
Study design
The first stage of the present study was directed to the discovery of SNPs in the coding regions of various subunits of GABA A receptors by direct DNA sequencing of PCR-amplified exons and of intronic sequences flanking each exon, with about 48 samples from each of the two subject groups. When the SNP rs252944, about 500 bp upstream to exon 8 of GABRB2 gene, showed promising association with schizophrenia, the study proceeded to the second stage. PCR was performed on genomic DNA flanking rs252944, spanning approximately 13 kb and consisting mostly of introns, on an expanded number of samples ( Table 1 ). The PCR products were completely sequenced to: (a) discover any SNPs in this region and (b) genotype these SNPs for potential association with schizophrenia.
Statistical analysis
All the SNPs analyzed were tested for HardyWeinberg equilibrium by means of the program GENEPOP v. 1.2 (GENEPOP website). 15 The complete enumeration method was chosen as suggested by GENEPOP.
Possible SNP association with susceptibility to schizophrenia was assessed by comparing the allelic and genotypic frequencies of schizophrenics and controls, using the standard w 2 -test under normal approximation. The level of significance was indicated by P-values, as implemented by the CLUMP program. 25 A value of Po0.05 was considered to be indicative of a statistically significant effect.
The two-loci and three-loci haplotype associations were carried out using the permutation and modelfree analysis (PMPLUS v.1.1) program 16, 17 in the estimated haplotype-frequencies (EHPLUS) software package. In view of the incomplete penetrance and uncertain mode of inheritance of schizophrenia, model-free analysis and permutation test were performed. PMPLUS implemented the model-free statistics by maximizing log-likelihood ratio statistic over a range of parameter values, instead of fixed values as in Mendelian dominant or recessive models. A recessive model with disease allele frequency 0.1 and penetrances 0.005, 0.005, 0.5 was initially assumed and inputted as the user-specified model. 26 PMPLUS prepared input files based on user-inputted data with different inheritance models, including the user-specified, recessive, dominant, model-free and heterogeneity models for EH. Maximum likelihood estimates of all the 10 two-loci haplotype frequencies were then performed by employing the expectationmaximization (EM) algorithm, 27 as implemented in EH. The hypotheses concerning different diseasemodel w 2 -statistics were performed by EH. In order to resolve the potential inaccurate significance level caused by asymptotic theory in association analyses of two-loci haplotypes, additional permutation procedures of 10 000 replicates were followed to obtain empirical P-values by means of EHPLUS. 16 LD between each pair of loci in the control group was tested using the standard LD coefficient 28 and the likelihood-ratio test, as implemented by the ARLE-QUIN program (ARLEQUIN website). For the standard LD coefficient calculation, two-loci haplotype frequencies were estimated using a maximum-likelihood approach from unphased diploid genotype data, as computed in the ARLEQUIN program. All measures of LD were based on D ¼ varies between 0 (no association) and 1 (maximum disequilibrium). For the likelihood-ratio tests, likelihood under the hypothesis of LD between loci is compared to the likelihood of the experimental data under LD. 29 Permutation procedure was performed in order to better approximate the underlying distribution of the likelihood ratio under the null hypothesis of linkage equilibrium. The significance level of LD was represented as P-value of the w 2 -test.
